Agenda

2024 NIDA-NIAAA Mini-Convention: Frontiers in Addiction Research
Friday, October 4, 2024
9:00 a.m. – 5:00 p.m. ALL TIMES CENTRAL
Marriott Marquis Chicago
Great Lakes Ballrooms ABC
2121 South Prairie Avenue
Chicago, IL

Please note, we will not have copies of the agenda onsite. If you need a paper copy, you can download here and print the agenda.

9:00 – 9:05 am	Introduction to the Mini-Convention Rita Valentino, Ph.D., Director, DNB, NIDA
9:05 – 10:10 am	Jacob P. Waletzky Memorial Award Lecture Introduction by George Koob, Ph.D., Director, NIAAA Awardee: Erin Calipari, Ph.D., Vanderbilt School of Medicine Rethinking Reward and Our Understanding of Neural Dysfunction and Behavior in Addiction
10:10 – 11:40 am	Scientific Session I. Psychoplastogens in the Treatment of Substance Use Disorders Co-Chairs: Jana Drgonova, Ph.D., NIDA Evan Herrmann, Ph.D., NIDA Speakers: Leandro Ruiz-Leyva, Ph.D., University of Alabama at Birmingham The 5-HT2A Receptor as a Therapeutic Target for Polydrug Opioid and Alcohol Misuse Jennifer Jones, M.D., Medical University of South Carolina Ketamine as a Psychoplastogen: Psychoactive Phenomenology, Clinical Effects, and Therapeutic Implications for Substance Use Disorders Frederick Barrett, Ph.D., Johns Hopkins University Effects of Psilocybin in Patients with Substance Use and Mood Disorders
11:40 am – 12:40 pm	Lunch Break (on your own) Hotel food & beverage options Nearby dining options
12:40 – 2:10 pm	Scientific Session II. GLP-1 Receptor Agonists for the Treatment of Substance Use Disorders Co-Chairs: Sam Ananthan, Ph.D., NIDA Mohammed Akbar, Ph.D., NIAAA Speakers: Luis Tuesta, Ph.D., University of Miami Cessation Through Satiety: Leveraging GLP-1 Signaling to Curb Nicotine and Substance Use Heath D. Schmidt, Ph.D., University of Pennsylvania GLP-1 Receptors and Midbrain Dopamine: Mechanisms of GLP-1R Modulation of Cocaine and Fentanyl Intake Christian Hendershot, Ph.D., University of Southern California GLP-1 Agonists as Novel Therapeutics for Alcohol Use Disorders Discussant: Joseph Schacht, Ph.D., University of Colorado
2:10 – 3:20 pm	Joint NIDAA-NIAAA Early Career Investigator Showcase Awardees: Iness Charfi, Ph.D., University of Montreal THC Modifies Microglial Phenotype and Induces Synaptic Pruning in Frontal Cortex of Adolescent Mice Samuel Centanni, Ph.D., Wake Forest University School of Medicine Insula-Bnst Circuit Regulation of Stress-Induced Susceptibility to Negative Affect in Ethanol Abstinence Shelley Warlow, Ph.D., Dartmouth College Mesohabenular GABA/Glutamate Projections Balance Postsynaptic Activity and Reinforcement Cecilia Hinojosa, Ph.D., Emory University School of Medicine; University of New Mexico Reward Neurocircuitry Predicts Longitudinal Changes in Alcohol Use Following Trauma Exposure Belgin Yalcin, Ph.D., Stanford University Myelin Plasticity in the Ventral Tegmental Area is Required for Opioid Reward Corinde Wiers, Ph.D., University of Pennsylvania Ketone Supplementation Dampens Subjective and Objective Responses to Alcohol in Rats and Humans
3:20 – 3:30 pm	Break
3:30 – 5:00 pm	Scientific Session III. The Habenula as an Anti-Addictive Circuit Hub Co-Chairs: Jonathan Pollock, Ph.D., NIDA Tristan McClure-Begley, Ph.D., NIDA Speakers: Emmanuel Darcq, Ph.D., French Institute of Health and Medical Research Mu Opioid Receptors in the Medial Habenula Contribute to Naloxone Aversion Paul Kenny, Ph.D., Icahn School of Medicine at Mount Sinai Hedgehog-Interacting Protein Acts in the Habenula to Regulate Nicotine Intake Thomas Jhou, Ph.D., University of Maryland Entopeduncular Nucleus Projections To The Lateral Habenula Contribute To Cocaine Avoidance Ines Ibanez-Tallon, Ph.D., The Rockefeller University Development of Habenular Circuit-Specific Therapies Targeting GPR151 for Nicotine and Opioid Addiction
5:00 pm	Closing Remarks